Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | L01AB02 |
UNII: | CO61ER3EPI |
InChI Key | YCPOZVAOBBQLRI-WDSKDSINSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C6H14O8S2 |
Molecular Weight | 278.3 |
AlogP | -2.34 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 127.2 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 16.0 |
Property Name | Value | Unit | Method |
---|---|---|---|
log P (octanol-water) | -3.350 | - | EST |
Henry's Law Constant | 6.90E-16 | atm-m3/mole | EST |
Atmospheric OH Rate Constant | 2.30E-11 | cm3/molecule-sec | EST |
Water Solubility | 1.00E+06 | mg/L | EST |
Vapor Pressure | 3.80E-10 | mm Hg | EST |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Sarcoma, Ewing | 3 | D012512 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
Myelodysplastic Syndromes | 3 | D009190 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
Hodgkin Disease | 2 | D006689 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 299-75-2 |
ChEBI | 82557 |
ChEMBL | CHEMBL455186 |
DrugBank | DB11678 |
DrugCentral | 2718 |
FDA SRS | CO61ER3EPI |
Guide to Pharmacology | 8281 |
KEGG | C19557 |
PubChem | 9882105 |
SureChEMBL | SCHEMBL5399430 |
ZINC | ZINC000001671094 |